EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Olaparib Enhances the Efficacy of Third‐Generation Oncolytic Adenoviruses Against Glioblastoma by Modulating DNA Damage Response and p66shc‐Induced Apoptosis

Yida Liu, Sheng Fang, Peiwen Wang, Junwen Zhang, Fusheng Liu iD

CNS Neuroscience & Therapeutics · 2024

DOI: 10.1111/cns.70124 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2024. Verfasst von Yida Liu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Brain Tumor Research Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Glioblastoma, Phthalazines, Piperazines, DNA Damage. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Capital Funds for Health Improvement and Research, Beijing Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Patients with glioblastoma multiforme (GBM) do not benefit from current cancer treatments, and their prognosis is dismal. This study aimed to investigate the potential synergistic effects of TS‐2021, a third‐generation oncolytic adenovirus, combined with the PARP inhibitor olaparib in GBM.

Methods

TS‐2021’s impact on p66shc‐induced apoptosis, DNA damage response, and poly (ADP‐ribose) polymerase (PARP) activation was evaluated in GBM cells. The synergistic effect of TS‐2021 and olaparib was examined in GBM cell lines and an immunocompetent mouse model of GBM. Mechanistic studies focused on the role of p66shc phosphorylation in the observed effects.

Results

TS‐2021 triggered p66shc‐induced apoptosis, DNA damage response, and PARP activation. The combination of TS‐2021 and olaparib synergistically increased cell apoptosis and DNA damage and reduced PARP expression compared to monotherapy. Olaparib promoted TS‐2021 replication and release in GBM cells. Mechanistically, olaparib combined with TS‐2021 upregulated p66shc phosphorylation, enhancing tumor cell apoptosis. In vivo, the combination therapy inhibited tumor growth and prolonged survival, confirming the synergistic effect.

Conclusion

This study is the first to suggest that TS‐2021 sensitizes GBM cells with wild‐type BRCA1/2 to olaparib. The combination of TS‐2021 and olaparib shows a synergistic therapeutic effect against GBM, providing a promising treatment strategy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaPhthalazinesPiperazinesDNA DamageApoptosisAdenoviridaeBrain NeoplasmsAnimalsHumansMiceCell Line, TumorSrc Homology 2 Domain-Containing, Transforming Protein 1Antineoplastic AgentsOncolytic VirusesPoly(ADP-ribose) Polymerase InhibitorsOncolytic VirotherapyCombined Modality Therapy

Stichwörter der Autor:innen

DNA damagePARPapoptosisglioblastomaoncolytic adenovirusp66shc

Substanzen

olaparibPhthalazinesPiperazinesSrc Homology 2 Domain-Containing, Transforming Protein 1Antineoplastic AgentsPoly(ADP-ribose) Polymerase Inhibitors

Autor:innen und Institutionen

  • Brain Tumor Research Center, Beijing Neurosurgical Institute, Capital Medical University, Beijing, China.
  • Department of Neurosurgery, Beijing Tiantan Hospital Affiliated to Capital Medical University, Beijing, China.
  • Beijing Laboratory of Biomedical Materials, Beijing, China.

ORCID-Profile: Fusheng Liu

Förderung

  • National Natural Science Foundation of China
  • Capital Funds for Health Improvement and Research
  • Beijing Municipal Health Commission

Zitieren

APA

Liu, Y., Fang, S., Wang, P., Zhang, J., & Liu, F. (2024). Olaparib Enhances the Efficacy of Third‐Generation Oncolytic Adenoviruses Against Glioblastoma by Modulating DNA Damage Response and p66shc‐Induced Apoptosis. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70124

Vancouver

Liu Y, Fang S, Wang P, Zhang J, Liu F. Olaparib Enhances the Efficacy of Third‐Generation Oncolytic Adenoviruses Against Glioblastoma by Modulating DNA Damage Response and p66shc‐Induced Apoptosis. CNS Neuroscience & Therapeutics. 2024. doi:10.1111/cns.70124

BibTeX
@article{Liu2024,
  author = {Liu, Yida and Fang, Sheng and Wang, Peiwen and Zhang, Junwen and Liu, Fusheng},
  title = {Olaparib Enhances the Efficacy of Third‐Generation Oncolytic Adenoviruses Against Glioblastoma by Modulating DNA Damage Response and p66shc‐Induced Apoptosis},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  doi = {10.1111/cns.70124}
}
Kostenlos starten →